Are you looking to expand your network, boost awareness and share your story?
This year, Bio Integrates have teamed up with Sciad, an industry specialist PR and communications agency, and Life Sciences Knowledge Hub, an online publication with a readership of 25,000 life sciences executives, to help you engage with the biotech and associated industries before, during and after the event on 20 May 2021.
Find out how we can improve your visibility by offering
1. a press release creation/distribution service 2. opportunity to submit editorials/video interviews
Scroll and click on the information below.
If you are a member of the press and would like to attend the event, please request a press pass.
LIVE ONLINE 20 May 2021
REQUEST A PRESS PASS
Over 400 attendees live on the day
The online digital event with real-time, face to face networking
1
day
90+
speakers
400+
senior industry executives
Our extended coverage opportunities include:
Click on the offers below to discover how you can get more exposure by being part of Bio Integrates 2021.
SCIAD Communications has a proven track record in turning complex science into compelling brand stories. By integrating brand, digital and PR we can help connect you with stakeholders to drive business development and build reputation.
Life Sciences Knowledge Hub is focused on the application of chemistry, biology and materials science to the discovery, development, formulation, manufacture and commercialization of pharmaceuticals, biotherapeutics, diagnostics and other supporting products and services within the life sciences sector.
Do you want to share your news with our community? Our Social Media reach includes 6,700 followers on Twitter and 9,000 connections on LinkedIn. Send your news to info@lsi-uk.com to be included in our communications plan.
CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development was proud to host Vaughan Gething MS, Welsh Minister of Economy, at its facility in Cardiff to open a new material science laboratory.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebral Dopamine Neurotrophic Factor), today announced that results from the Nanoform Proof of Concept (PoC) project show that the nanoforming process has been successfully applied to Herantis’ rhCDNF drug candidate.
SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK Biotek Ireland has been promoted to the office of President, SK biotek Ireland.
Life Sciences Knowledge Hub is focused on the application of chemistry, biology and materials science to the discovery, development, formulation, manufacture and commercialization of pharmaceuticals, biotherapeutics, diagnostics and other supporting products and services within the life sciences sector.
The magazine is published online, with print issues being produced for distribution at industry events. The total readership is about 25,000 life sciences executives, with about 40% of these based in Europe, 40% based in the USA, and 20% based in Asia (mainly in India, China and Japan). This readership is comprised of middle- and senior-level managers in companies specializing in fine chemicals, contract manufacture, formulation, small-molecule therapeutics (from start-ups to Big Pharma), biotechnology (from technology platform developers through contract manufacture to biotherapeutics companies), diagnostics, clinical development, clinical trials management and (bio)pharmaceutical commercialization, as well as in companies providing life sciences support services.
A unique opportunity
Working in partnership with Bio Integrates we have created a unique opportunity to engage with the biotech industry before, during and after the event. We will be offering the opportunity to submit editorials, interviews and video interviews. (see below examples)
Orgenesis - Cell and gene therapies are becoming well established as effective methods for treating disease: https://youtu.be/vY9tXkz2Fxk
Helsinn – Anticancer API facility: https://youtu.be/yhuBtE9G1qs
Companies will be working closely with our experienced editor Tom Mulligan. Tom is a qualified industrial chemist with more than 30 years of international experience in B2B publishing including chemical, pharmaceutical, biotechnology and related vertical markets. He is also a former director of highly successful technical and business strategy conferences in the pharmaceutical chemistry and biotechnology sectors.
The topics that we are looking to cover for this special issue will be following the three tracks:
Track one Connection – Finding the right investors, partners and vendors is key to accelerating the development and commercialisation of new products. How do you make the best connections?
Track two Reflection - 2020 was an unprecedented year. What impact has it had on biotech funding, pipelines and ecosystem?
Track three Projection - What does the future hold for life science investment and infrastructure?
This is a key opportunity to build relationship and trust and to directly engage with the audience and potential client ahead of the event.
Preparation is key… so don’t miss the opportunity to be seen and to see what’s hot in the biotech industry ahead of the event, mail jo.stickings@lsi-uk.com to register your interest.
